Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle

Silvia Riondino, Patrizia Ferroni, Antonella Spila, Jhessica Alessandroni, Roberta D'Alessandro, Vincenzo Formica, David Della Morte, Raffaele Palmirotta, Umberto Nanni, Mario Roselli, Fiorella Guadagni

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The growing demand of personalized medicine marked the transition from an empirical medicine to a molecular one, aimed at predicting safer and more effective medical treatment for every patient, while minimizing adverse effects. This passage has emphasized the importance of biomarker discovery studies, and has led sample availability to assume a crucial role in biomedical research. Accordingly, a great interest in Biological Bank science has grown concomitantly. In biobanks, biological material and its accompanying data are collected, handled and stored in accordance with standard operating procedures (SOPs) and existing legislation. Sample quality is ensured by adherence to SOPs and sample whole life-cycle can be recorded by innovative tracking systems employing information technology (IT) tools for monitoring storage conditions and characterization of vast amount of data. All the above will ensure proper sample exchangeability among research facilities and will represent the starting point of all future personalized medicine-based clinical trials.

Original languageEnglish (US)
Pages (from-to)291-300
Number of pages10
JournalCancer Genomics and Proteomics
Volume12
Issue number6
StatePublished - Nov 1 2015
Externally publishedYes

Fingerprint

Precision Medicine
Biomarkers
Life Cycle Stages
Medicine
Life cycle
Biological Science Disciplines
Legislation
Information Systems
Biomedical Research
Clinical Trials
Technology
Biological materials
Information technology
Research
Availability
Monitoring
Therapeutics

Keywords

  • Biobanking
  • Biomarker discovery
  • ICT tools
  • Review
  • Sample quality

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Cancer Research
  • Biochemistry

Cite this

Riondino, S., Ferroni, P., Spila, A., Alessandroni, J., D'Alessandro, R., Formica, V., ... Guadagni, F. (2015). Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle. Cancer Genomics and Proteomics, 12(6), 291-300.

Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle. / Riondino, Silvia; Ferroni, Patrizia; Spila, Antonella; Alessandroni, Jhessica; D'Alessandro, Roberta; Formica, Vincenzo; Della Morte, David; Palmirotta, Raffaele; Nanni, Umberto; Roselli, Mario; Guadagni, Fiorella.

In: Cancer Genomics and Proteomics, Vol. 12, No. 6, 01.11.2015, p. 291-300.

Research output: Contribution to journalArticle

Riondino, S, Ferroni, P, Spila, A, Alessandroni, J, D'Alessandro, R, Formica, V, Della Morte, D, Palmirotta, R, Nanni, U, Roselli, M & Guadagni, F 2015, 'Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle', Cancer Genomics and Proteomics, vol. 12, no. 6, pp. 291-300.
Riondino S, Ferroni P, Spila A, Alessandroni J, D'Alessandro R, Formica V et al. Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle. Cancer Genomics and Proteomics. 2015 Nov 1;12(6):291-300.
Riondino, Silvia ; Ferroni, Patrizia ; Spila, Antonella ; Alessandroni, Jhessica ; D'Alessandro, Roberta ; Formica, Vincenzo ; Della Morte, David ; Palmirotta, Raffaele ; Nanni, Umberto ; Roselli, Mario ; Guadagni, Fiorella. / Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle. In: Cancer Genomics and Proteomics. 2015 ; Vol. 12, No. 6. pp. 291-300.
@article{7052872eaee24a6199bee10b56760e03,
title = "Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle",
abstract = "The growing demand of personalized medicine marked the transition from an empirical medicine to a molecular one, aimed at predicting safer and more effective medical treatment for every patient, while minimizing adverse effects. This passage has emphasized the importance of biomarker discovery studies, and has led sample availability to assume a crucial role in biomedical research. Accordingly, a great interest in Biological Bank science has grown concomitantly. In biobanks, biological material and its accompanying data are collected, handled and stored in accordance with standard operating procedures (SOPs) and existing legislation. Sample quality is ensured by adherence to SOPs and sample whole life-cycle can be recorded by innovative tracking systems employing information technology (IT) tools for monitoring storage conditions and characterization of vast amount of data. All the above will ensure proper sample exchangeability among research facilities and will represent the starting point of all future personalized medicine-based clinical trials.",
keywords = "Biobanking, Biomarker discovery, ICT tools, Review, Sample quality",
author = "Silvia Riondino and Patrizia Ferroni and Antonella Spila and Jhessica Alessandroni and Roberta D'Alessandro and Vincenzo Formica and {Della Morte}, David and Raffaele Palmirotta and Umberto Nanni and Mario Roselli and Fiorella Guadagni",
year = "2015",
month = "11",
day = "1",
language = "English (US)",
volume = "12",
pages = "291--300",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Ensuring sample quality for biomarker discovery studies - Use of ict tools to trace biosample life-cycle

AU - Riondino, Silvia

AU - Ferroni, Patrizia

AU - Spila, Antonella

AU - Alessandroni, Jhessica

AU - D'Alessandro, Roberta

AU - Formica, Vincenzo

AU - Della Morte, David

AU - Palmirotta, Raffaele

AU - Nanni, Umberto

AU - Roselli, Mario

AU - Guadagni, Fiorella

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The growing demand of personalized medicine marked the transition from an empirical medicine to a molecular one, aimed at predicting safer and more effective medical treatment for every patient, while minimizing adverse effects. This passage has emphasized the importance of biomarker discovery studies, and has led sample availability to assume a crucial role in biomedical research. Accordingly, a great interest in Biological Bank science has grown concomitantly. In biobanks, biological material and its accompanying data are collected, handled and stored in accordance with standard operating procedures (SOPs) and existing legislation. Sample quality is ensured by adherence to SOPs and sample whole life-cycle can be recorded by innovative tracking systems employing information technology (IT) tools for monitoring storage conditions and characterization of vast amount of data. All the above will ensure proper sample exchangeability among research facilities and will represent the starting point of all future personalized medicine-based clinical trials.

AB - The growing demand of personalized medicine marked the transition from an empirical medicine to a molecular one, aimed at predicting safer and more effective medical treatment for every patient, while minimizing adverse effects. This passage has emphasized the importance of biomarker discovery studies, and has led sample availability to assume a crucial role in biomedical research. Accordingly, a great interest in Biological Bank science has grown concomitantly. In biobanks, biological material and its accompanying data are collected, handled and stored in accordance with standard operating procedures (SOPs) and existing legislation. Sample quality is ensured by adherence to SOPs and sample whole life-cycle can be recorded by innovative tracking systems employing information technology (IT) tools for monitoring storage conditions and characterization of vast amount of data. All the above will ensure proper sample exchangeability among research facilities and will represent the starting point of all future personalized medicine-based clinical trials.

KW - Biobanking

KW - Biomarker discovery

KW - ICT tools

KW - Review

KW - Sample quality

UR - http://www.scopus.com/inward/record.url?scp=84948776147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948776147&partnerID=8YFLogxK

M3 - Article

C2 - 26543078

AN - SCOPUS:84948776147

VL - 12

SP - 291

EP - 300

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 6

ER -